Valenta Farmatsevtika OAO: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
Valenta Farmatsevtika OAO Appoints Auditor for FY 2013-SKRIN
SKRIN reported that Valenta Farmatsevtika OAO has appointed AudiKons OOO as its auditor for the fiscal year 2013.
Latest Developments for Valenta Farmatsevtika OAO
Latest Key Developments in Pharmaceuticals
- FDA approves Gilead Sciences Inc's Sovaldi the treatment of Chronic Hepatitis C
- Auxilium Pharmaceuticals Inc's drug to treat bent penis condition gets U.S. approval - Reuters
- Innovus Pharmaceuticals Inc receives product license approval of EjectDelay for premature ejaculation from Health Canada
- GSK and Theravance announce positive results from pivotal phase iii study for fluticasone furoate/vilanterol in asthma
- Share this
- Digg this